“…Based on information from the two biochromatograms shown in Figures 1 and 2, material correlated with bioactivity as well as material suggested by LC-PDA-HRMS to be prenyl-or geranyl coumarin derivatives were isolated by preparative-scale HPLC followed by analytical-scale HPLC as detailed in the Materials and Methods section. This led to isolation of the new compounds 2, 5, 6, 8, 10, 11, 14, 15, 17-19, and 23-25 as well as identification of the known compounds marmesin (1) [28], 7-demethylsuberosin (3) [29], apigravin (4) [30], bothrioclinin (7) [31], (+)-2-[(2R)-6-acetyl-2,3-dihydro-5-hydroxybenzofuran-2-yl]-prop-2-enyl 15-methylbutanoate (8) [29], 3,5-bis-(isopent-2-en-1-yl)-4-hydroxyacetophenone (9) [32], 6-acetyl-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-2H-chromene (12) [33], and mutisicoumarin B (16) [34] by comparison of their 1 H NMR data with data from the literature. Retention times, HRESIMS, and 1 H NMR data for 1, 3, 4, 7-9, and 12 are given in Table S1 .…”